Treace Medical Concepts (TMCI) Change in Account Payables (2020 - 2026)
Treace Medical Concepts (TMCI) reported Change in Account Payables of $6.8 million for Q1 2026, up 152.17% on a YoY basis from $2.7 million in Q1 2025, and up 172.64% quarter-over-quarter from -$9.4 million in Q4 2025.
Treace Medical Concepts (TMCI) Change in Account Payables (2020 - 2026) Analysis & Trends
Treace Medical Concepts has reported Change in Account Payables for 7 years, with the latest figure at $6.8 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 152.17% year-over-year to $6.8 million; the trailing twelve-month figure through Mar 2026 stood at $314000.0 (up 103.96% YoY), and the FY2025 full-year result was -$3.8 million, down 189.11% from the prior year.
- Change in Account Payables for Q1 2026 stood at $6.8 million, up from -$9.4 million in the prior quarter.
- The five-year high for Change in Account Payables was $9.3 million in Q1 2024, with the low at -$9.4 million in Q4 2025.
- Historically, Change in Account Payables has averaged $557705.9 across 5 years, with a median of $576000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 1098.33% — and 2025, when it slumped 769.44%.
- Treace Medical Concepts' Change in Account Payables stood at $787000.0 in 2022, then jumped by 300.89% to $3.2 million in 2023, then slumped by 357.59% to -$8.1 million in 2024, then slipped by 15.38% to -$9.4 million in 2025, then surged by 172.64% to $6.8 million in 2026.
- The last three Change in Account Payables figures came in at $6.8 million (Q1 2026), -$9.4 million (Q4 2025), and -$3.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Treace Medical Concepts | 274.20 Mn | 222.34 Mn | 37.41 Mn | 6.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.81 Mn |
| Mar 31, 2026 | 6.81 Mn |
| Dec 31, 2025 | -9.38 Mn |
| Dec 31, 2025 | -9.38 Mn |
| Sep 30, 2025 | -3.86 Mn |
| Sep 30, 2025 | -3.86 Mn |
| Jun 30, 2025 | 6.74 Mn |
| Jun 30, 2025 | 6.74 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | -8.13 Mn |
| Dec 31, 2024 | -8.13 Mn |
| Sep 30, 2024 | 576,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -3.08 Mn |
| Mar 31, 2024 | 9.31 Mn |
| Mar 31, 2024 | 9.31 Mn |
| Dec 31, 2023 | 3.16 Mn |
| Dec 31, 2023 | 3.16 Mn |